[Federal Register Volume 62, Number 86 (Monday, May 5, 1997)]
[Notices]
[Pages 24449-24453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-11573]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Announcement 748]


Cooperative Agreements to Conduct Studies of Illnesses Among 
Persian Gulf War Veterans; Notice of Availability of Funds for Fiscal 
Year 1997

Introduction

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 1997 funds for a cooperative agreement 
to conduct studies of illnesses among Persian Gulf War (PGW) veterans.
    CDC is committed to achieving the health promotion and disease 
prevention objectives of ``Healthy People 2000,'' a national activity 
to reduce morbidity and mortality and improve quality of life. This 
announcement is related to the priority area of Environmental Health. 
(For ordering a copy of ``Healthy People 2000'' see the section WHERE 
TO OBTAIN ADDITIONAL INFORMATION.)

Authority

    This program is authorized under the Public Health Service Act, 
section 301 (42 USC 241).

Eligible Applicants

    Eligible applicants include all nonprofit and for-profit 
organizations. Thus, State and local health departments, State and 
local governmental agencies, universities, colleges, research 
institutions, hospitals, other public and private non-profit 
organizations, including small, minority and/or woman-owned businesses 
are eligible to apply.

    Note: An organization described in section 501(c)(4) of the 
Internal Revenue Code of 1986 which engages in lobbying activities 
shall not be eligible to receive Federal funds constituting an 
award, grant, contract, loan, or any other form.

    Applications will be considered for funding to conduct studies in 
one or more programmatic interest areas. Applicants interested in 
conducting more than one study must submit a separate application for 
each. If a single study addresses more than one programmatic interest 
area, only one should be identified as the primary interest area. The 
programmatic interest area should be clearly indicated for each study.

Smoke-Free Workplace

    CDC strongly encourages all grant recipients to provide a smoke-
free workplace and promote the non-use of all tobacco products and Pub. 
L. 103-227, the Pro-Children Act of 1994, prohibits smoking in certain 
facilities that receive Federal funds in which education, library, day 
care, health care, and early childhood development services are 
provided to children.

Availability of Funds

    Approximately $1.2 million will be available in FY 1997 to fund up 
to two cooperative agreements. It is expected that the average award 
will be up to $600,000 (direct and indirect costs). It is expected the 
award will begin on or about September 1, 1997, and will be made for a 
12-month budget period within a project period of up to three years. 
The funding estimate is subject to change based on the availability of 
funds.
    Applications which request more than the $600,000 per year cap will 
be returned to the applicant as non-responsive.
    Continuation awards within the project period will be made on the 
basis of satisfactory progress and the availability of funds.
    Applicants may enter into contracts, including consortia agreements 
(as set forth in the PHS Grants Policy Statement) as necessary to meet 
the requirements of the program and strengthen the overall application.

Use of Funds

Restrictions on Lobbying

    Applicants should be aware of restrictions on the use of HHS funds 
for lobbying of Federal or State legislative

[[Page 24450]]

bodies. Under the provisions of 31 USC Section 1352 (which has been in 
effect since December 23, 1989), recipients (and their subtier 
contractors) are prohibited from using appropriated Federal funds 
(other than profits from a Federal contract) for lobbying Congress or 
any Federal agency in connection with the award of a particular 
contract, grant, cooperative agreement, or loan. This includes grants/
cooperative agreements that, in whole or in part, involve conferences 
for which Federal funds cannot be used directly or indirectly to 
encourage participants to lobby or to instruct participants on how to 
lobby.
    In addition, the FY 1997 HHS Appropriations Act, which became 
effective October 1, 1996, expressly prohibits the use of 1997 
appropriated funds for indirect or ``grass roots'' lobbying efforts 
that are designed to support or defeat legislation pending before State 
legislatures. This new law, Section 503 of Pub. L. No. 104-208, 
provides as follows:
    Sec. 503(a) No part of any appropriation contained in this Act 
shall be used, other than for normal and recognized executive-
legislative relationships, for publicity or propaganda purposes, for 
the preparation, distribution, or use of any kit, pamphlet, booklet, 
publication, radio, television, or video presentation designed to 
support or defeat legislation pending before the Congress, * * * except 
in presentation to the Congress or any State legislative body itself.
    (b) No part of any appropriation contained in this Act shall be 
used to pay the salary or expenses of any grant or contract recipient, 
or agent acting for such recipient, related to any activity designed to 
influence legislation or appropriations pending before the Congress or 
any State legislature.
    Department of Labor, Health and Human Services, and Education, and 
Related Agencies Appropriations Act, 1997, as enacted by the Omnibus 
Consolidated Appropriations Act, 1997, Division A, Title I, Section 
101(e), Pub. L. No. 104-208 (September 30, 1996).

Background and Definitions

Background

    Between August 1990 and July 1991, approximately 697,000 U.S. 
military personnel were deployed to the Persian Gulf as part of 
Operations Desert Shield and Desert Storm. Shortly after returning to 
the U.S., many Persian Gulf War (PGW) veterans began to report a 
variety of symptoms which they suspect may be related to their military 
service in the Persian Gulf. The symptoms most commonly reported among 
PGW veterans have been fatigue, musculoskeletal complaints, and 
cognitive dysfunction. A variety of possible etiologies for PGW 
veterans' illnesses have been postulated. The possible etiologies have 
included infectious agents (e.g., leishmaniasis), environmental and 
ambient pollutants (e.g., sand, petroleum products, pesticides, 
Chemical Agent Resistant Coating (CARC) paint, and smoke from oil-well 
fires), medical prophylaxes (e.g., anthrax and botulinum toxin 
vaccines, and pyridostigmine bromide), depleted uranium munitions, and 
biologic and chemical warfare agents.
    Much of the current knowledge on the prevalence of illnesses among 
Gulf War veterans comes from self-referred registries established by 
the Department of Defense (DOD) and the Department of Veterans Affairs 
(VA). The DOD and VA Persian Gulf registries have added useful 
information on the spectrum of health concerns among Persian Gulf War 
veterans. The most recent analysis of DOD's Comprehensive Clinical 
Evaluation Program (CCEP) data on 18,598 Gulf War veterans found no 
evidence for a unique illness affecting Gulf War veterans. Instead CCEP 
participants reported a wide variety of symptoms affecting multiple 
organ systems. The most common primary diagnoses were psychological 
conditions (ICD-9-CM Codes 290-319--18.4%); symptoms, signs, and ill-
defined conditions (ICD-9-CM Codes 780-700--17.9%); and musculoskeletal 
system diseases (ICD-9-CM Codes 710-739--18.3%). However, these 
registries are of limited value as a database for determining the 
actual incidence and prevalence of illnesses because they are not 
representative of the population of Persian Gulf War veterans.
    In December 1994, the National Center for Environmental Health 
(NCEH) initiated, through the cooperative agreement mechanism, a 
population-based epidemiological study to evaluate the health 
consequences of a sample of PGW veterans. The purpose of this study was 
to compare the prevalence of self-reported symptoms and illnesses among 
PGW veterans from Iowa with military personnel from Iowa who were not 
deployed to the Persian Gulf. The study found that PGW veterans from 
Iowa were more likely than those who did not serve in the Gulf War to 
report symptoms suggestive of cognitive dysfunction, depression, 
chronic fatigue, post-traumatic stress disorder, respiratory illness 
(specifically asthma and bronchitis), fibromyalgia, alcohol abuse, 
generalized anxiety disorder, and sexual discomfort. The conditions 
identified in this study appear to have had a measurable impact on the 
functional activity and daily lives of these Persian Gulf War veterans. 
Among PGW veterans, minimal differences were observed between the 
National Guard or Reserve troops and the regular military personnel, 
indicating that all military personnel, regardless of type of military 
service, were affected by deployment to the Persian Gulf.
    Findings from this study established the need to investigate 
further the causes, clinical nature, and public health implications of 
the higher rates of self-reported health problems of PGW veterans. More 
objective clinical measurement of the specific conditions identified in 
this study should be addressed to determine the underlying illnesses, 
medical conditions, or other concerns that might be related to these 
self-reported conditions.
    The approach used in the Iowa study of PGW veterans was to assess 
the prevalence of known clinical entities. Other studies have used a 
data driven approach for assessing health differences between PGW 
veterans and other military populations. For example, in an 
investigation of PGW veterans from a Pennsylvania Air National Guard 
unit, investigators used factor analysis to develop a case definition 
of illness among PGW veterans. Additional research is needed to 
validate the case definition developed in the Pennsylvania study and to 
determine if data driven definitions or the use of known clinical 
diagnoses better characterizes illnesses among PGW veterans.

Definitions

    PGW veteran: A PGW veteran is defined as any regular duty or 
National Guard or reserve member who deployed to the Persian Gulf for 
some period from August 1, 1990, through July 31, 1991.
    PGW illnesses: PGW illnesses are defined as any adverse health 
outcome that is more prevalent among military personnel who deployed to 
the Persian Gulf than among non-deployed military personnel.
    PGW illnesses research projects: PGW illnesses research projects 
are defined as research designed to evaluate the health impact of 
military service in the Persian Gulf War.
    Veterans Service Organization: A congressionally chartered group of 
men and women who have served their country in uniform during either 
peace or war. Examples of veterans service organizations include but 
are not limited to, Paralyzed Veterans of America, Disabled American 
Veterans,

[[Page 24451]]

American Legion, Veterans of Foreign Wars, and American Veterans.

Purpose

    The purpose of this program is to:
    A. Build the scientific base for determining the nature and 
etiology of illnesses among PGW veterans.
    B. Evaluate the role of stress-related disorders on the current 
health status of PGW veterans.
    C. Determine if PGW veterans are experiencing a unique illness or 
are experiencing a higher prevalence of a variety of known clinical 
entities.
    D. Determine the health impact of military deployment to the 
Persian Gulf.
    E. Assess the best approach for developing a case-definition for 
illness among PGW veterans.

Program Requirements

    In conducting activities to achieve the purpose of these 
cooperative agreements, the recipient will need to meet the 
requirements and is responsible for the activities under A. (Recipient 
Activities). CDC will be responsible for the activities under B. (CDC 
Activities).

A. Recipient Activities

    1. Collaborate with CDC and the appropriate State or local Health 
Department during the development and conduct of the study, and 
dissemination of the results.
    2. Obtain approval of study procedures by an appropriate 
institutional review committee.
    3. Develop and pilot test the study protocol and data collection 
instruments.
    4. Provide timelines for completing all components of the study.
    5. Assure and maintain the confidentiality of all study 
participants.
    6. Conduct the analysis, interpretation, presentation, and 
reporting of the study findings in collaboration with CDC.
    7. Upon completion of the study, provide CDC an electronic version 
of the final data set stripped of personal identifiers.
    8. Act as the focal point for the development and dissemination of 
media releases, reports and publications.
    9. Establish an independent Public Advisory Committee comprised of 
representatives from the State or local Health Department, local 
Veterans' Service Organizations, PGW veterans, other affected parties, 
and CDC.

B. CDC Activities

    1. Serve as collaborators in the development, analysis, and conduct 
of the study, as well as reporting and publishing of study findings.
    2. Provide expert review, and comment on all study protocols, data 
collection instruments, analysis plans, media releases, draft and final 
reports, and publications generated by the recipient.
    3. Serve as the principal point of contact with the Department of 
Defense, Department of Veterans Affairs, and other Federal agencies to 
secure names and locating information for the study participants.
    4. Coordinate the related activities of the involved Federal 
legislative bodies, agencies, and national veterans service 
organizations.
    5. Serve as a member on the Public Advisory Committee.

Programmatic Priorities

    Applicants must propose research that enhances the understanding of 
conditions and symptoms reported to be more prevalent among PGW 
veterans, or adds to the scientific knowledge needed to develop a case 
definition of illness among PGW veterans.
    Enhance the understanding of conditions and symptoms reported to be 
more prevalent among PGW veterans. Conduct research on conditions known 
to be more prevalent among PGW veterans. These conditions include 
cognitive dysfunction, depression, anxiety disorders, chronic fatigue, 
post-traumatic stress disorder, other stress-related disorders, 
respiratory illness (specifically asthma and bronchitis), fibromyalgia, 
and alcohol abuse. These studies should include appropriate clinical 
evaluation in order to validate the diagnosis, assessment of the course 
of the illness among PGW veterans, assessment of risk factors, and 
assessment of the impact of the illness on functional status.
    Characterization of illnesses among PGW veterans. Conduct studies 
focusing on development of a case-definition for illness among PGW 
veterans. These studies should evaluate whether symptoms reported among 
PGW veterans represent a unique illness or are better characterized by 
existing clinical entities. This should include a comparison of data 
driven case-definitions and use of known clinical diagnoses in order to 
determine the best way to characterize illness among PGW. It may also 
include validation of previous data driven case definitions of 
illnesses among Gulf War veterans.

Reporting Requirements

    An original and two copies of the Financial Status Report (FSR) are 
due within 90 days after the end of each budget period. An original and 
two copies of the technical semi-annual reports, using the format 
below, are due 30 days after the end of each quarter to the CDC Grants 
Management Officer.
    The semi-annual progress report must include the following for each 
program, function, or activity involved:

A. Highlights

     Discuss issues and activities that had significant impact 
on the program and that you wish to bring to the attention of CDC.
     Discuss any changes in program personnel, especially 
changes affecting those involved with the grant.

B. Objectives and Achievements

     List major objectives and discuss your progress in meeting 
these objectives.
     Summarize your accomplishments for the period and for the 
budget year.
     Mention anything that either helped or hindered your 
achieving these objectives.

Application Content

    All applications must be developed in accordance with the 
instructions that are contained in this program announcement, Form PHS 
398, ERRATA sheet, and the instructions outlined in the following 
section headings. Applicants must identify in a cover letter one of the 
topics previously outlined under the heading Programmatic Priorities 
upon which their project is focused.
    The following are application requirements: 
    1. A principal investigator who has conducted research, published 
the findings, and has specific authority and responsibility to carry 
out the proposed project.
    2. Demonstrate the commitment of veterans service organizations to 
serve on a Public Advisory Committee by securing letters of support 
from at least three veterans' service organizations, as described under 
the heading, ``Definitions.''
    3. The applicant must provide a one page abstract outlining the 
plans, objectives, and expected outcomes of the proposed research.
    Provide a succinct but informative response to each requirement. 
Your response must not exceed 2 pages (letters of support may be 
referenced to where they are located in the application). This response 
must appear as the first 2 pages of the text of your application and be 
titled ``Program Requirements.'' An affirmative response to each 
question is required to qualify for further review. Those that do not

[[Page 24452]]

respond will be determined as non-responsive and will be returned to 
the applicant.
    Applications for these cooperative agreements should include: 
A. Description of the Problem to be Addressed
    1. The project's focus that justifies the research need and 
describes the scientific basis for the research, the expected outcome, 
and the relevance of the findings to reduce morbidity among PGW 
veterans.
    2. Describe the issues related to requirements, problems, 
complexities, and interactions required in developing the study.
    3. Discuss past experiences with similar projects.
B. Goals and Objectives
    1. For each of the elements (item C below) provide specific, 
measurable, and time-framed objectives that are consistent with the 
applicants proposed theme, purpose, and objectives.
C. Program Plan
    1. A detailed plan describing the elements of the research project 
and the methods by which the objectives will be achieved, including 
their sequence.
    2. Discuss the administrative and scientific capacity critical to 
the development and conduct of the study.
    3. A description of the involvement of the State or local Health 
Department, veteran service organizations, and other affected parties 
to ensure they have ample input during all phases of the study. It 
should include commitments of support and a clear statement of their 
roles.
    4. Describe the State agency linkages and support that will be used 
during the development, conduct, and conclusion of the study.
D. Management and Staffing Plan
    1. A description of the role and responsibilities of the project's 
principal investigator. Describe research background, publications, 
specific authority and responsibilities to carryout the proposed 
project.
    2. A description of all the project staff regardless of their 
funding source. It should include their title, qualifications, 
experience, percentage of time each will devote to the project, as well 
as that portion of their salary to be paid by the grant.
    3. A description of all key contractor staff, their role in the 
study, and their resumes.
    4. A description of those activities related to, but not proposed 
to be supported by the grant.
E. Evaluation
    Describe how progress toward meeting the study objectives will be 
evaluated. A comprehensive evaluation plan is an essential component of 
the application.
F. Budget
    1. A detailed first year budget for the project with future annual 
projections.
    2. A budget projection that clearly separates and distinguishes 
direct and indirect costs.
    An applicant organization has the option of having specific salary 
and fringe benefit amounts for individuals omitted from the copies of 
the application which are made available to outside reviewing groups. 
To exercise this option: on the original and five copies of the 
application, the applicant must use asterisks to indicate those 
individuals for whom salaries and fringe benefits are not shown; the 
subtotals must still be shown. In addition, the applicant must submit 
an additional copy of page four of Form PHS-398, completed in full, 
with the asterisks replaced by the salaries and fringe benefits. This 
budget page will be reserved for internal staff use only.

Evaluation Criteria

    Upon receipt, applications will be screened by CDC staff for 
completeness and responsiveness. Incomplete applications and 
applications that are not responsive will be returned to the applicant 
without further consideration. Applications which are complete and 
responsive will be evaluated by an independent Special Emphasis Panel 
(SEP) according to the following criteria:
    1. Understanding the Problem (5 points).
    The background of the proposal, i.e., the basis for the present 
proposal, the critical evaluation of existing knowledge, and specific 
identification of the knowledge gaps which the proposal is intended to 
fill.
    2. Measurable Objectives (10 points).
    Specific, measurable, and time-framed objectives that are 
consistent with the applicants proposed theme, purpose, and hypotheses 
to be tested.
    3. Proposed Plan (75 points).
    a. The significance and originality from a scientific or technical 
standpoint of the specific aims of the proposed research, including the 
adequacy of the theoretical and conceptual framework for the research. 
(5 points)
    b. The overall match between the applicant's proposed theme and 
research objectives, and the program priorities as described under the 
heading ``Programmatic Priorities.'' (15 points)
    c. The adequacy of the proposed research design, approaches, and 
methodology to carry out the research, including quality assurance 
procedures, plan for data management, and statistical analysis plans. 
The degree to which the applicant has met the CDC Policy requirements 
regarding the inclusion of women, ethnic, and racial groups in the 
proposed research. This includes: (a) The proposed plan for the 
inclusion of both sexes and racial and ethnic minority populations for 
appropriate representation; (b) the proposed justification when 
representation is limited or absent; (3) a statement as to whether the 
design of the study is adequate to measure differences when warranted; 
and (4) a statement as to whether the plans for recruitment and 
outreach for study participants include the process of establishing 
partnerships with community(ies) and recognition of mutual benefits 
will be documented. (25 points)
    d. The degree of commitment and cooperation of other interested 
parties as evidenced by letters of commitment detailing the nature and 
extent of the involvement. (10 points)
    e. Qualifications, adequacy, and appropriateness of personnel to 
accomplish the proposed activities. Demonstrated experience in 
conducting, evaluating, and publishing research on the health effects 
of military service on the applicants project team. (10 points)
    f. Adequacy of existing and proposed facilities and resources. (10 
points)
    4. Proposed Evaluation Plan (10 points).
    The extent to which the evaluation plan will allow for the 
measurement of progress toward the achievement of the stated 
objectives.
    5. Budget (Not Scored).
    The reasonableness of the proposed budget to the proposed research.
    Continuation awards within the project period will be made on the 
basis of the availability of funds and the following criteria:
    1. The accomplishments reflected in the progress report of the 
continuation application indicate that the applicant is meeting 
previously stated objectives and timelines contained in the project 
proposal and satisfactory progress has been demonstrated through 
monitoring work-in-progress.
    2. The objectives for the new budget period are realistic, 
specific, and measurable.
    3. The methods described will clearly lead to achievement of these 
objectives.
    4. The evaluation plan will allow management to monitor whether the 
methods are effective.

[[Page 24453]]

    5. The budget request is clearly explained, adequately justified, 
reasonable and consistent with the intended use of cooperative 
agreement funds.

Executive Order 12372 Review

    Applications are not subject to the review requirements of 
Executive Order 12372.

Public Health System Reporting Requirements

    This program is not subject to the Public Health System Reporting 
Requirements.

Catalog of Federal Domestic Assistance Number

    The Catalog of Federal Domestic Assistance Number is 93.283.

Other Requirements

Paperwork Reduction Act

    Projects that involve the collection of information from 10 or more 
individuals and funded by these cooperative agreements will be subject 
to approval by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act.

Human Subjects

    If the proposed project involves research on human subjects, the 
applicant must comply with the Department of Health and Human Services 
Regulations, 45 CFR Part 46, regarding the protection of human 
subjects. Assurance must be provided to demonstrate that the project 
will be subject to initial and continuing review by appropriate 
institutional review committees. The applicant will be responsible for 
providing assurance in accordance with the appropriate guidelines and 
forms provided in the application kit.

Women and Minority Inclusion Policy

    It is the policy of the CDC to ensure that women and racial and 
ethnic groups will be included in CDC supported research projects 
involving human subjects, whenever feasible and appropriate. Racial and 
ethnic groups are those defined in OMB Directive No. 15 and include 
American Indian, Alaskan Native, Asian, Pacific Islander, Black and 
Hispanic. Applicants shall ensure that women, racial and ethnic 
minority populations are appropriately represented in applications for 
research involving human subjects. Where clear and compelling rationale 
exist that inclusion is inappropriate or not feasible, this situation 
must be explained as part of the application.
    In conducting the review of applications for scientific merit, 
review groups will evaluate proposed plans for inclusion of minorities 
and both sexes as part of the scientific assessment and assigned score. 
This policy does not apply to research studies when the investigator 
cannot control the race, ethnicity and/or sex of subjects. Further 
guidance to this policy is contained in the Federal Register, Vol. 60, 
No. 179, Friday, September 15, 1995, pages 47947-47951.

Application Submission and Deadlines

A. Pre-application Letter of Intent

    Although not a prerequisite of application, a non-binding letter of 
intent-to-apply is requested from potential applicants. The letter 
should be submitted to the Grants Management Specialist (whose address 
is reflected in section B, ``Applications''). It should be postmarked 
no later than June 2, 1997. The letter should identify the announcement 
number, name the principal investigator, and specify the priority area 
of study the proposal addresses as outlined under the section 
Programmatic Priorities. The letter of intent does not influence review 
or funding decisions, but it will enable CDC to plan the review more 
efficiently, and will ensure that each applicant receives timely and 
relevant information prior to application submission.

B. Applications

    Applicants should use Form PHS-398 (OMB No. 0925-0001 Revised 5/95) 
and adhere to the ERRATA Instruction Sheet for Form PHS-398 contained 
in the Grant Application Kit.
    Please submit an original and five copies, on or before July 8, 
1997 to: Lisa G. Tamaroff, Grants Management Specialist, Grants 
Management Branch, Procurement and Grants Office, Centers for Disease 
Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Room 321, 
Atlanta, Georgia 30305, telephone (404) 842-6796 or internet: 
lgt1.cdc.gov.

C. Deadlines

    1. Applications shall be considered as meeting a deadline if they 
are either:
    A. Received at the above address on or before the deadline date, or
    B. Sent on or before the deadline date to the above address, and 
received in time for the review process. Applicants should request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or the U.S. Postal Service. Private 
metered postmarks shall not be acceptable as proof of timely mailings.
    2. Applications which do not meet the criteria above are considered 
late applications and will be returned to the applicant.

Where to Obtain Additional Information

    To receive a complete program description, information on 
application procedures and application forms call (404) 332-4561. You 
will be asked to leave your name, address, and the telephone number and 
will need to refer to Announcement 748. Business management technical 
information may be obtained from Lisa Tamaroff, Grants Management 
Specialist, Grants Management Branch, Procurement and Grants Office, 
Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry 
Road, NE., Mailstop E-13, Atlanta, GA 30305, telephone (404) 842-6796 
or internet: lgt1.cdc.gov.
    Programmatic technical assistance may be obtained from Phillip M. 
Talboy, Project Officer, Veterans' Health Activity, Division of 
Environmental Hazards and Health Effects, National Center for 
Environmental Health, Centers for Disease Control and Prevention (CDC), 
Mailstop F-28, 4770 Buford Highway, NE., Atlanta, Georgia 30341-3724, 
telephone (770) 488-7347, internet: pmt0.cdc.gov.
    This and other CDC announcements are also available through the CDC 
homepage on the Internet. The address for the CDC homepage is http://
www.cdc.gov.
    CDC will not send application kits by facsimile or express mail.
    Please refer to Announcement Number 748 when requesting information 
and submitting an application.
    Potential applicants may obtain a copy of Healthy People 2000 (Full 
Report, Stock No. 017-001-00474-0) or Healthy People 2000 (Summary 
Report, Stock No. 017-001-00473-1) through the Superintendent of 
Documents, Government Printing Office, Washington, DC, 20402-9325, 
telephone (202) 512-1800.

    Dated: April 29, 1997.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 97-11573 Filed 5-2-97; 8:45 am]
BILLING CODE 4163-18-P